GTS Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-103,600
Closed -$91.8M 2835
2024
Q3
$91.8M Buy
103,600
+12,200
+13% +$11M 0.2% 54
2024
Q2
$82.8M Sell
91,400
-2,300
-2% -$1.84M 0.18% 55
2024
Q1
$72.9M Buy
93,700
+10,700
+13% +$7.61M 0.13% 66
2023
Q4
$48.4M Sell
83,000
-2,700
-3% -$1.58M 0.08% 130
2023
Q3
$46M Buy
+85,700
New +$44.2M 0.08% 128

Other funds holding LLY

GTS Securities's LLY Position: Q2 2026 in Review

GTS Securities reduced its Eli Lilly (LLY) stake by 53% in Q2 2026, selling an estimated $2M and leaving 1,764 shares worth $2.12M. The position accounts for 0.04% of the portfolio, ranked #241.

GTS Securities first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $14.7M in Q3 2024. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • GTS Securities held 1,764 shares of Eli Lilly worth $2.12M as of Q2 2026.
  • GTS Securities sold 1,955 Eli Lilly shares in Q2 2026, an estimated $2M.
  • Eli Lilly made up 0.04% of GTS Securities's portfolio in Q2 2026, its #241 holding.
  • GTS Securities first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • GTS Securities's Eli Lilly position peaked at $14.7M in Q3 2024.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.